Zanivan Sara, Krueger Marcus, Mann Matthias
Vascular Proteomics Group, Beatson Institute for Cancer Research, Glasgow, UK.
Methods Mol Biol. 2012;757:435-50. doi: 10.1007/978-1-61779-166-6_25.
Mass spectrometry-based proteomics is a field that has been quickly developing, enabling increasingly giving in-depth characterization of the proteomes of cells and tissues. Current technology allows identifying thousands of proteins in a single experiment. Stable isotope labeling with amino acid in cell culture (SILAC) was originally developed for high accuracy quantitative proteomic studies in cell lines. We have shown that SILAC can be extended to in vivo animal model by fully labeling C57BL/6 mice with (13)C(6)-Lysine (Lys6). We used SILAC mice technology to map quantitative proteomic changes in mice lacking the expression of β1 integrin, β-Parvin, or the integrin tail-binding protein Kindlin-3. This approach confirmed the absence of the proteins and revealed a role of Kindlin-3 in red blood cells. Here we describe a practical method to generate and maintain a colony of SILAC mice and optimal strategies to perform in vivo quantitative proteomic experiments.
基于质谱的蛋白质组学是一个快速发展的领域,能够越来越深入地表征细胞和组织的蛋白质组。目前的技术允许在一次实验中鉴定数千种蛋白质。细胞培养中氨基酸稳定同位素标记(SILAC)最初是为细胞系中的高精度定量蛋白质组学研究而开发的。我们已经表明,通过用(13)C(6)-赖氨酸(Lys6)完全标记C57BL/6小鼠,SILAC可以扩展到体内动物模型。我们使用SILAC小鼠技术来绘制缺乏β1整合素、β-Parvin或整合素尾部结合蛋白Kindlin-3表达的小鼠的定量蛋白质组变化。这种方法证实了这些蛋白质的缺失,并揭示了Kindlin-3在红细胞中的作用。在这里,我们描述了一种生成和维持SILAC小鼠群体的实用方法以及进行体内定量蛋白质组学实验的最佳策略。